Hypertension Clinical Trial
Official title:
The Potential Link Between HCMV Infection and Essential Hypertension
It has been reported that mouse cytomegalovirus infection alone can elevate the blood
pressure in mice. Since HCMV has uniquely evolved with its human host, with little genetic
similarity to the animal CMV counterparts, and it only replicates in human, an
epidemiological study is required to define the relevance of HCMV infection and expression
of hcmv-miRNA-UL112 to the pathogenesis of essential hypertension.
The investigators found that hcmv-miR-UL112, a human cytomegalovirus (HCMV)-encoded miRNA,
was highly expressed in the hypertensive patients. Among the top miRNA target predictions,
the investigators demonstrate that IRF-1 is a direct target gene of hcmv-miR-UL112, along
with MICB that has been previously reported. Both IRF-1 and MICB play critical roles in
immuno/inflammatory and anti-infection response. Thus, the investigators speculated that
IRF-1 and MICB repression by hcmv-miR-UL112 could be considered a unifying mechanism that
evades the host response at several levels: antiviral, inflammatory, and immune. In
addition, there is an increasing evidence that IRF-1 may be important in apoptosis,
angiogenesis, neointima formation and the pathogenesis of vascular diseases. IRF-1 can
up-regulate angiotensin II type 2 receptor (AGTR2) that exerts antiproliferative and
proapoptotic actions and affects regulation of blood pressure. It has been reported that the
targeted disruption of the mouse AGTR2 gene resulted in a significant increase in blood
pressure and increased sensitivity to angiotensin II. The nitric oxide synthase expression
and NO synthesis in macrophages and distinct cardiomyocytes are induced and controlled by
IRF-1 in response to inflammation, important steps in vascular biology that may improve
endothelial function and inhibit smooth muscle cell migration, and a key pathophysiological
event in hypertension. Collectively, these reports support a strong relationship between
IRF-1 regulation and hypertension, indicating a potential role of hcmv-miR-UL112 and HCMV
infection in the pathogenesis of hypertension.Thus, the investigators want to investigate
the potential link between HCMV infection and essential hypertension.
n/a
Observational Model: Case Control, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |